Love, Richard. “By the Metrics Surgical Oophorectomy Plus Tamoxifen Is the First Adjuvant Treatment Option for Premenopausal Women With Hormone Receptor Positive Breast Cancer”. Archives of Breast Cancer (January 28, 2021): 8–13. Accessed June 3, 2025. https://www.archbreastcancer.com/index.php/abc/article/view/337.